TORL BioTherapeutics
Culver City, CA
TORL BioTherapeutics is a clinical-stage biopharmaceutical business focused on creating innovative, antibody-based medicines to improve the lives of cancer patients. They are developing a comprehensive pipeline of innovative preclinical ADCs and mAb in oncologic diseases with high unmet medical needs.
torlbio.comCompany Details
Founded
- 2018
Employees
- Between 10 - 100 employees
Raised
- $412,000,000
Headquarters Location
- Culver City, CA
Public
- No
Acquired
- No
CEO
Mark Alles
Founders
- Dennis SlamonNeil O'Brien
Company Collections
These are collections TORL BioTherapeutics is a part of. Click on the collection name to view similar companies.